Fiche centre
Hôpital Pitié-Salpêtrière
Paris — France
Essais liés5clinical trials
VilleParislocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07037459
Essais cliniques associés
5| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Maridebart cafraglutide | Insuffisance cardiaque | Phase 3 | NCT07037459 | MARITIME-HF — Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity | RECRUITING |
| Radotinib HCl 50 mg | Parkinson | Phase 2 | NCT04691661 | Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease | ACTIVE_NOT_RECRUITING |
| Cenerimod | Lupus | Phase 3 | NCT05648500 | OPUS-1 — A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus | ACTIVE_NOT_RECRUITING |
| SonoCloud-4 (SC4) device | Sclérose latérale amyotrophique | Phase 1/2 | NCT07571486 | Son-ALS — Therapeutic Approach of Repeated Transient Blood-brain Barrier Opening in Amyotrophic Lateral Sclerosis. | RECRUITING |
| Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection | SEP | Phase 2 | NCT03910738 | TOTEM-RRMS — TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis | RECRUITING |